Cited by 15Chronic Kidney Disease and DiabetesArtificial Intelligence in HealthcareDiabetes Management and Research

Clinical study of different prediction models in predicting diabetic nephropathy in patients with type 2 diabetes mellitus

Open access
Cai, Sha-Sha, Zheng, Teng-Ye, Wang, Kang-Yao, Zhu, Hui-Ping·2024·World Journal of Diabetes

Abstract

BACKGROUND Among older adults, type 2 diabetes mellitus (T2DM) is widely recognized as one of the most prevalent diseases. Diabetic nephropathy (DN) is a frequent complication of DM, mainly characterized by renal microvascular damage. Early detection, aggressive prevention, and cure of DN are key to improving prognosis. Establishing a diagnostic and predictive model for DN is crucial in auxiliary diagnosis. AIM To investigate the factors that impact T2DM complicated with DN and utilize this information to develop a predictive model. METHODS The clinical data of 210 patients diagnosed with T2DM and admitted to the First People’s Hospital of Wenling between August 2019 and August 2022 were retrospectively analyzed. According to whether the patients had DN, they were divided into the DN group (complicated with DN) and the non-DN group (without DN). Multivariate logistic regression analysis was used to explore factors affecting DN in patients with T2DM. The data were randomly split into a training set (n = 147) and a test set (n = 63) in a 7:3 ratio using a random function. The training set was used to construct the nomogram, decision tree, and random forest models, and the test set was used to evaluate the prediction performance of the model by comparing the sensitivity, specificity, accuracy, recall, precision, and area under the receiver operating characteristic curve. RESULTS Among the 210 patients with T2DM, 74 (35.34%) had DN. The validation dataset showed that the accuracies of the nomogram, decision tree, and random forest models in predicting DN in patients with T2DM were 0.746, 0.714, and 0.730, respectively. The sensitivities were 0.710, 0.710, and 0.806, respectively; the specificities were 0.844, 0.875, and 0.844, respectively; the area under the receiver operating characteristic curve (AUC) of the patients were 0.811, 0.735, and 0.850, respectively. The Delong test results revealed that the AUC values of the decision tree model were lower than those of the random forest and nomogram models (P < 0.05), whereas the difference in AUC values of the random forest and column-line graph models was not statistically significant (P > 0.05). CONCLUSION Among the three prediction models, random forest performs best and can help identify patients with T2DM at high risk of DN.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4239/wjd.v15.i1.43

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. [1]Magliano DJ Boyko EJ IDF Diabetes Atlas 10th edition scientific committee IDF DIABETES ATLAS [Internet]. Brussels: International Diabetes Federation; 2021– 35914061
  2. [2]American Diabetes Association 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020 Diabetes Care 2020 43 S14 S31 31862745
  3. [3]Rosolowsky ET Skupien J Smiles AM Niewczas M Roshan B Stanton R Eckfeldt JH Warram JH Krolewski AS Risk for ESRD in type 1 diabetes remains high despite renoprotection J Am Soc Nephrol 2011 22 545 553 21355053 PMC3060448
  4. [4]Luk AOY Hui EMT Sin MC Yeung CY Chow WS Ho AYY Hung HF Kan E Ng CM So WY Yeung CK Chan KS Chan KW Chan PF Siu SC Tiu SC Yeung VTF Chan JCN Chan FWK Cheung C Cheung NT Ho ST Lam KSL Yu LWL Chao D Lau IT Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database Diabetes Care 2017 40 928 935 28490423
  5. [5]de Boer IH Rue TC Hall YN Heagerty PJ Weiss NS Himmelfarb J Temporal trends in the prevalence of diabetic kidney disease in the United States JAMA 2011 305 2532 2539 21693741 PMC3731378
  6. [6]Afkarian M Zelnick LR Hall YN Heagerty PJ Tuttle K Weiss NS de Boer IH Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014 JAMA 2016 316 602 610 27532915 PMC5444809
  7. [7]Handelman GS Kok HK Chandra RV Razavi AH Lee MJ Asadi H eDoctor: machine learning and the future of medicine J Intern Med 2018 284 603 619 30102808
  8. [8]ElSayed NA Aleppo G Aroda VR Bannuru RR Brown FM Bruemmer D Collins BS Hilliard ME Isaacs D Johnson EL Kahan S Khunti K Leon J Lyons SK Perry ML Prahalad P Pratley RE Seley JJ Stanton RC Gabbay RA on behalf of the American Diabetes Association 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023 Diabetes Care 2023 46 S19 S40 36507649 PMC9810477
  9. [9]Tsur A Harman-Bohem I Buchs AE Raz I Wainstein J [The guidelines for the diagnosis prevention and treatment of type 2 diabetes mellitus--2005] Harefuah 2006 145 583 586, 630 16983842
  10. [10]Li L Yang Y Zhu X Xiong X Zeng L Xiong S Jiang N Li C Yuan S Xu H Liu F Sun L Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients J Diabetes 2020 12 237 246 31602779
  11. [11]Qi C Mao X Zhang Z Wu H Classification and Differential Diagnosis of Diabetic Nephropathy J Diabetes Res 2017 2017 8637138 28316995 PMC5337846
  12. [12]Samsu N Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment Biomed Res Int 2021 2021 1497449 34307650 PMC8285185
  13. [13]Kanwar YS Sun L Xie P Liu FY Chen S A glimpse of various pathogenetic mechanisms of diabetic nephropathy Annu Rev Pathol 2011 6 395 423 21261520 PMC3700379
  14. [14]Wagnew F Eshetie S Kibret GD Zegeye A Dessie G Mulugeta H Alemu A Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis BMC Res Notes 2018 11 565 30081966 PMC6080368
  15. [15]Zhang XX Kong J Yun K Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies J Diabetes Res 2020 2020 2315607 32090116 PMC7023800
  16. [16]Tziomalos K Athyros VG Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis Rev Diabet Stud 2015 12 110 118 26676664 PMC5397986
  17. [17]Hu Y Shi R Mo R Hu F Nomogram for the prediction of diabetic nephropathy risk among patients with type 2 diabetes mellitus based on a questionnaire and biochemical indicators: a retrospective study Aging (Albany NY) 2020 12 10317 10336 32484786 PMC7346021
  18. [19]Zhou DM Wei J Zhang TT Shen FJ Yang JK Establishment and Validation of a Nomogram Model for Prediction of Diabetic Nephropathy in Type 2 Diabetic Patients with Proteinuria Diabetes Metab Syndr Obes 2022 15 1101 1110 35431563 PMC9005335
  19. [20]Xi C Wang C Rong G Deng J A Nomogram Model that Predicts the Risk of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Retrospective Study Int J Endocrinol 2021 2021 6672444 33897777 PMC8052141
  20. [21]Nagel G Zitt E Peter R Pompella A Concin H Lhotta K Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population BMC Nephrol 2013 14 177 23962027 PMC3765663
  21. [22]Zhu Y Wang X Wang W Wang H Zhang F Expression and influence of pentraxin-3, HbAlc and ApoA1/ApoB in serum of patients with acute myocardial infarction combined with diabetes mellitus type 2 Exp Ther Med 2018 15 4395 4399 29731826 PMC5920826
  22. [23]Hu H Nakagawa T Honda T Yamamoto S Okazaki H Yamamoto M Miyamoto T Eguchi M Kochi T Shimizu M Murakami T Tomita K Ogasawara T Sasaki N Uehara A Kuwahara K Kabe I Mizoue T Sone T Dohi S Japan Epidemiology Collaboration on Occupational Health Study Group Low serum creatinine and risk of diabetes: The Japan Epidemiology Collaboration on Occupational Health Study J Diabetes Investig 2019 10 1209 1214 PMC6717816 30756513
  23. [24]Ninković V Ninković S Zivojinović D [Cardiovascular autonomous dysfunction in diabetics: the influence of disease duration, glycoregulation degree and diabetes type] Srp Arh Celok Lek 2008 136 488 493 19069339
  24. [25]Saini DC Kochar A Poonia R Clinical correlation of diabetic retinopathy with nephropathy and neuropathy Indian J Ophthalmol 2021 69 3364 3368 34708806 PMC8725070
  25. [26]Li Y Su X Ye Q Guo X Xu B Guan T Chen A The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies Ren Fail 2021 43 231 240 33478336 PMC7833016
  26. [27]Bamber JH Evans SA The value of decision tree analysis in planning anaesthetic care in obstetrics Int J Obstet Anesth 2016 27 55 61 27026589
  27. [28]Lv J Liu YY Jia YT He JL Dai GY Guo P Zhao ZL Zhang YN Li ZX A nomogram model for predicting prognosis of obstructive colorectal cancer World J Surg Oncol 2021 19 337 34857001 PMC8638364
  28. [29]Uddin S Khan A Hossain ME Moni MA Comparing different supervised machine learning algorithms for disease prediction BMC Med Inform Decis Mak 2019 19 281 31864346 PMC6925840
  29. [30]Tseng PY Chen YT Wang CH Chiu KM Peng YS Hsu SP Chen KL Yang CY Lee OK Prediction of the development of acute kidney injury following cardiac surgery by machine learning Crit Care 2020 24 478 32736589 PMC7395374
  30. [31]Hu M Shu X Yu G Wu X Välimäki M Feng H A Risk Prediction Model Based on Machine Learning for Cognitive Impairment Among Chinese Community-Dwelling Elderly People With Normal Cognition: Development and Validation Study J Med Internet Res 2021 23 e20298 33625369 PMC7946590

Cited by

Sorted by citations

Authors
Cai, S.-S., Zheng, T.-Y., Wang, K.-Y., & Zhu, H.-P.
Affiliations
The First People's Hospital of Wenling (CN)
Venue
World Journal of Diabetes
Published
2024-01-15
Volume
15
Issue
1
Pages
43-52
ISSN
1948-9358 (ISSN-L)
OpenAlex
W4390823975
Cited by
15
References
1
Citations by year
2026: 5 · 2025: 9 · 2024: 1
FWCI
4.28
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Diabetes (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Science and Technology Commission of Shanghai Municipality (15140902900)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetic nephropathy, type 2 diabetes, risk prediction model, nomogram, decision tree, random forest, risk factors, diagnostic accuracy comparison, risk stratification, risk intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review